ResearcherHouston MethodistActive in the last 2 years

Greyson W. G. Biegert

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1413-6630; OpenAlex author ID A5057071422. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper

Papers 1

Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.omton.2025.201006 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Qizhi Cathy Yao · 1 shared paper, 2025 · strength 0.24
- Paper Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinom… DOI 10.1016/j.omton.2025.201006 ↗
Ryu Matsumoto · 1 shared paper, 2025 · strength 0.24
- Paper Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinom… DOI 10.1016/j.omton.2025.201006 ↗
Masataka Suzuki · 1 shared paper, 2025 · strength 0.24
- Paper Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinom… DOI 10.1016/j.omton.2025.201006 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.